glp-1 heart issues receptor agonists and myocardial metabolism in atrial fibrillation Poll: 1 in 8 Adults

The researchers were investigating how GLP-1s impact someones cardiovascular health

The Oral GLP-1 Revolution: How Pill-Based Drugs Are Reshaping the Obesity Treatment Space Table of Contents Summary The obesity drug landscape is shifting from injectable GLP-1s to oral pill-based treatments, marking a major turning point in pharmacotherapy

Its important to remember that semaglutide GLP-1 is not a magic solution, but a tool to be incorporated into a broader strategy involving a healthy diet and regular physical exercise for the best results

While Mounjaro is not approved for weight loss, Eli Lilly was granted a fast-track designation for tirzepatide to treat people with obesity in October 2022

Many insurance plans explicitly exclude anti-obesity medications, classifying them as non-essential or lifestyle-related treatments